Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
System and method for measuring an analyte in a sample
One-dimensional metal nanostructures
Highly stable electrolytic water with reduced NMR half line width
Antenna device
Process for the preparation of ethylene homopolymers or copolymers in a high-pressure reactor controlled by a model based predictive controller
Spray drying vancomycin
Dynamically reconfigurable systolic array accelorators
  Randomly Featured Patents
Laying head with segmented laying pipe
Grids for nuclear fuel assemblies
Device for breaking at least one continuous rod in a machine for making products for smokers
Apparatus for forming large-dimension ceramic tiles
Apparatus for attachment of heart valve holder to heart valve prosthesis
Ink supply mechanism and inkjet recording apparatus including the ink supply mechanism
Step-down unit incorporated in large scale integrated circuit
Multi-cylinder stirling engine
Stabilizing clay with hydroxy-aluminum and base
Portable shelter/garment